Mads Jorgen Nohr Clausen
Presidente en Clausen Controls Holding Ii ApS .
Cargos activos de Mads Jorgen Nohr Clausen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MC2 Therapeutics Ltd.
 MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Director/Miembro de la Junta | 25/06/2008 | - |
Clausen Controls Holding Ii ApS
 Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Presidente | 04/05/2022 | - |
Historial de carrera de Mads Jorgen Nohr Clausen
Estadísticas
Internacional
| Reino Unido | 2 |
| Dinamarca | 2 |
Operativa
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
MC2 Therapeutics Ltd.
MC2 Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Part of Mc2 Therapeutics AS, MC2 Therapeutics Ltd. develops pharmaceutical products for chronic inflammatory conditions. The company is based in Leatherhead, UK and was founded in 2005. | Health Technology |
Clausen Controls Holding Ii ApS
Clausen Controls Holding Ii ApS Financial ConglomeratesFinance Clausen Controls Holding II ApS is an investment holding Danish company. The private company is based in Sonderborg, Denmark. Jens Martin Skibsted has been the CEO of the company since 2022. | Finance |
